Organization:Gynecologic Oncology Group
| Abbreviation | GOG |
|---|---|
| Formation | 1970 |
| Type | Nonprofit organization |
| Headquarters | Philadelphia, Pennsylvania |
| Website | www |
The Gynecologic Oncology Group (GOG) is a nonprofit organization funded by the National Cancer Institute to support research on the prevention and treatment of gynecologic cancers, including ovarian cancer, cervical cancer, endometrial cancer, vulvar cancer, and vaginal cancer.
History
The GOG was founded in 1970[1] by a group of gynecologic surgeons from 11 institutions. The formation of the GOG was the result of the recognition of the need for collaborative research in the gynecologic malignancies. The GOG has now grown to include over 50 research centers and has over 160 affiliated institutions. Its members make up a multi-disciplinary group, consisting of gynecologic oncologists, medical oncologists, pathologists, radiation oncologists, nurses, statisticians, and basic scientists.
Over 3,000 patients are treated each year on GOG protocols. As of 2024, the GOG has completed over 350 clinical trials.[1]
References
- ↑ 1.0 1.1 "GOG Foundation Overview". GOG Foundation. https://www.gog.org/about/. Retrieved 6 November 2024.
External links
 |  |
